These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


302 related items for PubMed ID: 11555522

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS.
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H, Ghofrani HA, Walmrath D, Schermuly R, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical value of vasodilator test with inhaled nitric oxide for predicting long-term response to oral vasodilators in pulmonary hypertension.
    Morales-Blanhir J, Santos S, de Jover L, Sala E, Paré C, Roca J, Rodriguez-Roisin R, Barberà JA.
    Respir Med; 2004 Mar; 98(3):225-34. PubMed ID: 15002758
    [Abstract] [Full Text] [Related]

  • 9. Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics.
    Matamis D, Pampori S, Papathanasiou A, Papakonstantinou P, Tsagourias M, Galiatsou E, Koulouras V, Nakos G.
    Circ Heart Fail; 2012 Jan; 5(1):47-53. PubMed ID: 22057829
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Hervé P, Simonneau G.
    Circulation; 2005 Jun 14; 111(23):3105-11. PubMed ID: 15939821
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension.
    Krowka MJ, Frantz RP, McGoon MD, Severson C, Plevak DJ, Wiesner RH.
    Hepatology; 1999 Sep 14; 30(3):641-8. PubMed ID: 10462369
    [Abstract] [Full Text] [Related]

  • 16. A Comparison of Inhaled Nitric Oxide Versus Inhaled Epoprostenol for Acute Pulmonary Hypertension Following Cardiac Surgery.
    McGinn K, Reichert M.
    Ann Pharmacother; 2016 Jan 14; 50(1):22-6. PubMed ID: 26438636
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xu QX, Yang YH, Geng J, Zhai ZG, Gong JN, Li JF, Tang X, Wang C.
    Chin Med J (Engl); 2017 Feb 20; 130(4):382-391. PubMed ID: 28218209
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.